At Precision Biomonitoring Inc., we envision a world where we can instantly identify any organism on the spot, anywhere in the world. Founded in 2016, Precision Biomonitoring is a rapidly scaling, commercial stage molecular diagnostics company. Our proprietary technologies include our commercially available TripleLockTM PCR platform and our lateral flow platform Voilà!TM platform, both which aim to deliver rapid, accurate, on-site environmental, food, animal and human diagnostic testing solutions. As we continue to grow our human molecular diagnostics business, we are looking to explore potential partnership opportunities to enhance our commercial portfolio through product and technology in-licensing, acquisition or other collaboration models.

Precision Biomonitoring Logo



Event details

Date: June 10 - 17, 2021

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


30 in total